Buyback

Zydus Lifesciences discloses insider share transactions under SEBI regulations related to its recent buyback offer. Promoter Zydus Family Trust accepted 63.5 lakh shares, reducing its holding from 74.

Cyient Limited proposes to buy back up to 64 lakh equity shares at ₹1,125 per share for an aggregate consideration of ₹720 crore through a tender offer. The buyback excludes promoters and reserves 15%